{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:07:12Z","timestamp":1783922832131,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118055","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:48:51Z","timestamp":1778712531000},"page":"118055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["The CRIP1\/NFATC2\/SREBF1 axis drives melanoma progression by promoting reactive oxygen species-mediated endoplasmic reticulum stress activation"],"prefix":"10.1016","volume":"251","author":[{"given":"Ting","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping\u2019an","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118055_b0005","doi-asserted-by":"crossref","unstructured":"B. Ahmed, M.I. Qadir, S. Ghafoor, Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment, Critical reviews in eukaryotic gene expression 30(4) (2020) 291-297.","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454"},{"issue":"10","key":"10.1016\/j.bcp.2026.118055_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105384","article-title":"Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction","volume":"23","author":"T\u00edm\u00e1r","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.det.2022.07.017","article-title":"Melanoma classification and management in the era of molecular medicine","volume":"41","author":"Rashid","year":"2023","journal-title":"Dermatol. Clin."},{"issue":"4","key":"10.1016\/j.bcp.2026.118055_b0020","first-page":"367","article-title":"Melanoma: diagnosis and treatment","volume":"110","author":"Lauters","year":"2024","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.bcp.2026.118055_b0025","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","article-title":"Global trends in melanoma burden: a comprehensive analysis from the global burden of disease Study, 1990-2021","volume":"92","author":"Sun","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118055_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CM9.0000000000003416","article-title":"Recent global patterns in skin cancer incidence, mortality, and prevalence","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J. (Engl)"},{"issue":"5","key":"10.1016\/j.bcp.2026.118055_b0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol."},{"issue":"16","key":"10.1016\/j.bcp.2026.118055_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164026","article-title":"BRAF mutations in melanoma: biological aspects, therapeutic implications, and circulating biomarkers","volume":"15","author":"Castellani","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bcp.2026.118055_b0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/bjd\/ljaf178","article-title":"Targeting the MAPK pathway for NRAS mutant melanoma: from mechanism to clinic","volume":"193","author":"Wang","year":"2025","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bcp.2026.118055_b0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","article-title":"Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment","volume":"59","author":"Marzagalli","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118055_b0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cps.2021.05.002","article-title":"Canonical signaling pathways in melanoma","volume":"48","author":"Sun","year":"2021","journal-title":"Clin. Plast. Surg."},{"issue":"3","key":"10.1016\/j.bcp.2026.118055_b0065","first-page":"163","article-title":"Melanoma development: current knowledge on melanoma pathogenesis","volume":"27","author":"Lugovi\u0107-Mihi\u0107","year":"2019","journal-title":"Acta Dermatovenerol. Croatica : ADC"},{"key":"10.1016\/j.bcp.2026.118055_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104435","article-title":"Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond","volume":"201","author":"Colombino","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12964-022-00989-y","article-title":"PI3K\/AKT signaling allows for MAPK\/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma","volume":"20","author":"Corrales","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12967-023-04200-9","article-title":"The role of mitochondria in the resistance of melanoma to PD-1 inhibitors","volume":"21","author":"Du","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118055_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2025.114580","article-title":"Coumarins and betulinic acid analogues from Mammea americana and their inhibitory activities on oncogenic MAPK\/ERK and PI3K\/AKT pathways in human melanoma cells","volume":"238","author":"Han","year":"2025","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bcp.2026.118055_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116122","article-title":"Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma","volume":"223","author":"Wang","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41420-022-01221-z","article-title":"Extracellular vesicles microRNA-592 of melanoma stem cells promotes metastasis through activation of MAPK\/ERK signaling pathway by targeting PTPN7 in non-stemness melanoma cells","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2026.118055_b0100","doi-asserted-by":"crossref","unstructured":"A.L. Becker, A.K. Indra, Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies, Cancers (Basel) 15(11) (2023).","DOI":"10.3390\/cancers15113038"},{"issue":"20","key":"10.1016\/j.bcp.2026.118055_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204483","article-title":"Nutrient-based approaches for melanoma: prevention and therapeutic insights","volume":"15","author":"Dong","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/15548627.2024.2395142","article-title":"Hypoxia-induced BNIP3 facilitates the progression and metastasis of uveal melanoma by driving metabolic reprogramming","volume":"21","author":"Sun","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2026.118055_b0115","doi-asserted-by":"crossref","unstructured":"S. Demirsoy, S. Martin, H. Maes, P. Agostinis, Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma, Frontiers in oncology 6 (2016) 240.","DOI":"10.3389\/fonc.2016.00240"},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41420-025-02617-3","article-title":"Metabolic reprogramming in melanoma therapy","volume":"11","author":"Shen","year":"2025","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41392-023-01314-w","article-title":"SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation","volume":"8","author":"Yi","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118055_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113741","article-title":"Endoplasmic reticulum stress in melanoma pathogenesis and resistance","volume":"155","author":"Kong","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0135","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1038\/s41598-017-17888-9","article-title":"The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone","volume":"7","author":"Eigner","year":"2017","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.bcp.2026.118055_b0140","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100871","article-title":"Redox signals at the ER-mitochondria interface control melanoma progression","volume":"38","author":"Zhang","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2026.118055_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1208690","article-title":"ROS as regulators of cellular processes in melanoma","volume":"2021","author":"Venza","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41420-025-02395-y","article-title":"Cysteine-rich intestinal protein family: structural overview, functional diversity, and roles in human disease","volume":"11","author":"Ye","year":"2025","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.bcp.2026.118055_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2687867","article-title":"Comprehensive analysis of CRIP1 in patients with ovarian cancer, including ceRNA network, immune-infiltration pattern, and clinical benefit","volume":"2022","author":"Qi","year":"2022","journal-title":"Disease markers"},{"key":"10.1016\/j.bcp.2026.118055_b0160","doi-asserted-by":"crossref","unstructured":"Z. Wu, B. Qu, M. Yuan, J. Liu, C. Zhou, M. Sun, Z. Guo, Y. Zhang, Y. Song, Z. Wang, CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis, Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10(26) (2023) e2303246.","DOI":"10.1002\/advs.202303246"},{"issue":"12","key":"10.1016\/j.bcp.2026.118055_b0165","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1136\/gutjnl-2022-329349","article-title":"CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-\u03baB\/p65 nuclear translocation in pancreatic ductal adenocarcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.bcp.2026.118055_b0170","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021110218","article-title":"CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma","volume":"41","author":"Wang","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2026.118055_b0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.lfs.2018.05.054","article-title":"CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt\/\u03b2\u2011catenin signaling pathway","volume":"207","author":"Zhang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118055_b0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-10-8","article-title":"Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1","volume":"10","author":"Mena","year":"2012","journal-title":"J. Transl. Med."},{"issue":"40","key":"10.1016\/j.bcp.2026.118055_b0185","article-title":"USP45 represses melanoma development by deubiquitinating and stabilizing tumor suppressor MRGPRF","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bcp.2026.118055_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107776","article-title":"Inflammatory signaling pathways in pancreatic beta-cell: new insights into type 2 diabetes pathogenesis","volume":"216","author":"Chen","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0195","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1038\/s41598-021-86493-8","article-title":"JAK\/STAT inhibitor therapy partially rescues the lipodystrophic autoimmune phenotype in Clec16a KO mice","volume":"11","author":"Pandey","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118055_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118055_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153678","article-title":"Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc\/HIF-1alpha pathway","volume":"91","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.bcp.2026.118055_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/nu17101682","article-title":"Ginsenoside Rh2 mitigates endoplasmic reticulum stress-induced apoptosis and inflammation and through inhibition of hepatocyte-macrophage inflammatory crosstalk","volume":"17","author":"Park","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12964-025-02295-9","article-title":"SREBF1 mediates immunoparalysis of dendritic cells in sepsis by regulating lipid metabolism and endoplasmic reticulum stress","volume":"23","author":"Zhang","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.bcp.2026.118055_b0220","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2026.118055_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109249","article-title":"Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response","volume":"118","author":"Lin","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2026.118055_b0230","article-title":"Oncogenic role of the NFATC2\/NEDD4\/FBP1 axis in cholangiocarcinoma","volume":"103","author":"Zhao","year":"2023","journal-title":"Labor. Investig."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13018","article-title":"NFATC1 and NFATC2 expression patterns in human osteochondromas","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.bcp.2026.118055_b0240","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s12325-023-02555-5","article-title":"Management of advanced invasive melanoma: new strategies","volume":"40","author":"Villani","year":"2023","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2026.118055_b0245","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/1440-1681.12436","article-title":"ER stress-induced autophagy in melanoma","volume":"42","author":"Meng","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bcp.2026.118055_b0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biochi.2022.01.017","article-title":"The unfolded protein response and the biology of uveal melanoma","volume":"197","author":"Zhang","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2026.118055_b0255","doi-asserted-by":"crossref","unstructured":"C. Amalinei, A. Grigora\u0219, L. Lozneanu, I.D. C\u0103runtu, S.E. Giu\u0219c\u0103, R.A. Balan, The Interplay between Tumour Microenvironment Components in Malignant Melanoma, Medicina (Kaunas, Lithuania) 58(3) (2022).","DOI":"10.3390\/medicina58030365"},{"key":"10.1016\/j.bcp.2026.118055_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2020.108321","article-title":"Oncogenic BRAF, endoplasmic reticulum stress, and autophagy: crosstalk and therapeutic targets in cutaneous melanoma","volume":"785","author":"Rather","year":"2020","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0265","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1038\/s41598-025-88373-x","article-title":"CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118055_b0270","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15203","article-title":"Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma","volume":"11","author":"Tan","year":"2023","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.bcp.2026.118055_b0275","article-title":"The roles and mechanisms of SREBP1 in cancer development and drug response","volume":"11","author":"He","year":"2024","journal-title":"Genes Dis."},{"issue":"22","key":"10.1016\/j.bcp.2026.118055_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212387","article-title":"Oxidative stress and cancer therapy: controlling cancer cells using reactive oxygen species","volume":"25","author":"Ju","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118055_b0285","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","article-title":"Endoplasmic reticulum stress-a key guardian in cancer","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discovery"},{"issue":"22","key":"10.1016\/j.bcp.2026.118055_b0290","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41388-019-0729-2","article-title":"An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells","volume":"38","author":"Perotti","year":"2019","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bcp.2026.118055_b0295","first-page":"1202","article-title":"The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress","volume":"19","author":"Raghu","year":"2021","journal-title":"Curr. Neuropharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:27:20Z","timestamp":1783920440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"alternative-id":["S0006295226003886"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118055","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CRIP1\/NFATC2\/SREBF1 axis drives melanoma progression by promoting reactive oxygen species-mediated endoplasmic reticulum stress activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118055"}}